Skip to main content
SpringerLink
Log in

Withdrawing antiepileptic drugs in seizure-free patients: what are the cognitive benefits?

  • Practice Point
  • Published:

From Nature Clinical Practice Neurology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ortinski P and Meador KJ (2004) Cognitive side effects of antiepileptic drugs. Epilepsy Behav 5 (Suppl 1): S60–S65

    Article  Google Scholar 

  2. Cochrane HC et al. (1998) Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards. Epilepsia 30: 1088–1097

    Article  Google Scholar 

  3. Chadwick D and Privitera M (2006) How skeptical should we be about industry-sponsored studies? Neurology 67: 378–379

    Article  Google Scholar 

  4. Sillanpaa A and Schmidt D (2006) Prognosis of seizure recurrence after stopping antiepileptic drugs in seizure-free patients: a long-term population based study of childhood-onset epilepsy. Epilepsy Behav 8: 713–719

    Article  CAS  Google Scholar 

  5. Specchio LM and Beghi E (2004) Should antiepileptic drugs be withdrawn in seizure-free patients? Drugs 18: 201–212

    CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Institute of Neurology, IRCCS C Mondino Foundation and Clinical Pharmacology Unit, University of Pavia, Piazza Botta 10, 27100 Pavia, Italy perucca@unipv.it

Authors and Affiliations

  1. E Perucca is Professor of Clinical Pharmacology and Director of the Laboratories for Diagnostics and Applied Biological Research at the IRCCS C Mondino Foundation, Pavia, Italy.,

    Emilio Perucca

Authors
  1. Emilio Perucca
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author has received speaker’s or consultancy fees and/or research grants from the manufacturers of carbamazepine and oxcarbazepine (Novartis), gabapentin, phenytoin and pregabalin (Pfizer), lamotrigine (GSK), levetiracetam (UCB Pharma), tiagabine, valproic acid and vigabatrin (sanovi-aventis), topiramate (Johnson & Johnson) and zonisamide (Eisai).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perucca, E. Withdrawing antiepileptic drugs in seizure-free patients: what are the cognitive benefits?. Nat Rev Neurol 3, 194–195 (2007). https://doi.org/10.1038/ncpneuro0449

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0449

  • Springer Nature Limited

Search

Navigation